Exact Mass: 680.2410056

Exact Mass Matches: 680.2410056

Found 36 metabolites which its exact mass value is equals to given mass value 680.2410056, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Foscan

3-[7,12,17-tris(3-hydroxyphenyl)-21,22,23,24-tetraazapentacyclo[16.2.1.1³,⁶.1⁸,¹¹.1¹³,¹⁶]tetracosa-1,3,5,7,11(23),12,14,16,18(21),19-decaen-2-yl]phenol

C44H32N4O4 (680.2423431999999)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XD - Sensitizers used in photodynamic/radiation therapy D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents D000970 - Antineoplastic Agents C1420 - Photosensitizing Agent D003879 - Dermatologic Agents Same as: D06066

   

6'-O-alpha-D-Galactopyranosylciceritol

(1S,2R,3S,4R,5S,6S)-4-methoxy-6-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-({[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-({[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}cyclohexane-1,2,3,5-tetrol

C25H44O21 (680.2374973999999)


6-O-alpha-D-Galactopyranosylciceritol is found in pulses. 6-O-alpha-D-Galactopyranosylciceritol is isolated from chickpea Isolated from chickpeas. 6-O-alpha-D-Galactopyranosylciceritol is found in pulses.

   

berbamine dihydrochloride

berbamine dihydrochloride

C37H40N2O6.2[HCl] (680.2419772000002)


   

Scorodioside

Scorodioside

C32H40O16 (680.231624)


   

3-(3-Methylbutyl)tricetin 5-neohesperidoside

3-(3-Methylbutyl)tricetin 5-neohesperidoside

C32H40O16 (680.231624)


   

(+/-)-2-hydroxy-5-benzylisouvarinol-B|(+/-)-2-hydroxy-5-benzylisouvarinol-B5|2 -hydroxy-5-benzylisouvarinol-B|5-Benzyl-2-hydroxyisouvarinol B

(+/-)-2-hydroxy-5-benzylisouvarinol-B|(+/-)-2-hydroxy-5-benzylisouvarinol-B5|2 -hydroxy-5-benzylisouvarinol-B|5-Benzyl-2-hydroxyisouvarinol B

C43H36O8 (680.2410056)


   

2-(4-hydroxy-3-methoxyphenyl)ethyl 2-O-acetyl-4-O-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]-3-O-alpha-L-rhamnopyranosyl-beta-D-glucopyranoside|salsaside E

2-(4-hydroxy-3-methoxyphenyl)ethyl 2-O-acetyl-4-O-[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]-3-O-alpha-L-rhamnopyranosyl-beta-D-glucopyranoside|salsaside E

C32H40O16 (680.231624)


   

kinginoside

kinginoside

C32H40O16 (680.231624)


   

C32H40O16

C32H40O16 (680.231624)


   

Javanicoside C

Javanicoside C

C32H40O16 (680.231624)


   

6-O-trans-cinnamoylgenipin gentiobioside

6-O-trans-cinnamoylgenipin gentiobioside

C32H40O16 (680.231624)


   

scrospioside B

scrospioside B

C32H40O16 (680.231624)


   

2-O-acetyl-3-O-methylverbascoside

2-O-acetyl-3-O-methylverbascoside

C32H40O16 (680.231624)


   

15G256alpha-2|15G256alpha-2 (2)

15G256alpha-2|15G256alpha-2 (2)

C32H40O16 (680.231624)


   

(3S)-7,4-di-O-glucosyldiphysolone

(3S)-7,4-di-O-glucosyldiphysolone

C32H40O16 (680.231624)


   

sinapyl alcohol 9-O-caffeoyl-4-O-alpha-rhamnopyranosyl-(1->2)-beta-glucopyranoside|solargin II

sinapyl alcohol 9-O-caffeoyl-4-O-alpha-rhamnopyranosyl-(1->2)-beta-glucopyranoside|solargin II

C32H40O16 (680.231624)


   

2 -hydroxy-3 -benzyluvarinol|3-Benzyl-2-hydroxyuvarinol

2 -hydroxy-3 -benzyluvarinol|3-Benzyl-2-hydroxyuvarinol

C43H36O8 (680.2410056)


   

5-O-neohesperidoside-asplenetin

5-O-neohesperidoside-asplenetin

C32H40O16 (680.231624)


   

2 -hydroxy-5 -benzylisouvarinol-A|5-Benzyl-2-hydroxyisouvarinol A

2 -hydroxy-5 -benzylisouvarinol-A|5-Benzyl-2-hydroxyisouvarinol A

C43H36O8 (680.2410056)


   

dichotellide J|gemmacolide F

dichotellide J|gemmacolide F

C32H40O16 (680.231624)


   

pycnamine

(1S,14R)-20,21,25-trimethoxy-15,30-dimethyl-7,23-dioxa-15,30-diazaheptacyclo[2 2.6.2.2<3,6>.1<8,12>.1<14,18>.0<22,36>.0<27,31>]hexatriaconta-3,5,8(35),9,11,1 8(36),19,21,24(32),25,27(31),33-dodecaen-9-ol, chloride, chloride

C37H42Cl2N2O6 (680.2419772000001)


Berbamine dihydrochloride is an inhibitor of NF-κB activity with remarkable anti-myeloma efficacy. Berbamine dihydrochloride is an inhibitor of NF-κB activity with remarkable anti-myeloma efficacy.

   

C32H40O16_beta-D-Glucopyranoside, (1aS,1bS,2S,5aR,6S,6aS)-6-[[3-O-acetyl-6-deoxy-2-O-[(2E)-1-oxo-3-phenyl-2-propen-1-yl]-alpha-L-mannopyranosyl]oxy]-1a,1b,2,5a,6,6a-hexahydro-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl

NCGC00169849-02_C32H40O16_beta-D-Glucopyranoside, (1aS,1bS,2S,5aR,6S,6aS)-6-[[3-O-acetyl-6-deoxy-2-O-[(2E)-1-oxo-3-phenyl-2-propen-1-yl]-alpha-L-mannopyranosyl]oxy]-1a,1b,2,5a,6,6a-hexahydro-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl

C32H40O16 (680.231624)


   

C32H40O16_(1aS,1bS,2S,5aR,6S,6aS)-6-({3-O-Acetyl-6-deoxy-4-O-[(2E)-3-phenyl-2-propenoyl]-alpha-L-mannopyranosyl}oxy)-1a-(hydroxymethyl)-1a,1b,2,5a,6,6a-hexahydrooxireno[4,5]cyclopenta[1,2-c]pyran-2-yl beta-L-glucopyranoside

NCGC00385207-01_C32H40O16_(1aS,1bS,2S,5aR,6S,6aS)-6-({3-O-Acetyl-6-deoxy-4-O-[(2E)-3-phenyl-2-propenoyl]-alpha-L-mannopyranosyl}oxy)-1a-(hydroxymethyl)-1a,1b,2,5a,6,6a-hexahydrooxireno[4,5]cyclopenta[1,2-c]pyran-2-yl beta-L-glucopyranoside

C32H40O16 (680.231624)


   

Hydroxypropyl Methyl Cellulose

2-({6-[(6-{[4,5-dihydroxy-2-(hydroxymethyl)-6-methoxyoxan-3-yl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl)oxy]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl}oxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C25H44O21 (680.2374973999999)


   

6''-O-a-D-Galactopyranosylciceritol

(1S,2R,3S,4R,5S,6S)-4-methoxy-6-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-({[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-({[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}cyclohexane-1,2,3,5-tetrol

C25H44O21 (680.2374973999999)


   

d-tubocurarine chloride

(+)-Tubocurarine chloride hydrochloride

C37H42Cl2N2O6 (680.2419772000001)


D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant

   

TEMOPORFIN

TEMOPORFIN

C44H32N4O4 (680.2423431999999)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XD - Sensitizers used in photodynamic/radiation therapy D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents D000970 - Antineoplastic Agents C1420 - Photosensitizing Agent D003879 - Dermatologic Agents

   

Sarmentosumin A

Sarmentosumin A

C43H36O8 (680.2410056)


A natural product found in Piper sarmentosum.

   

Sarmentosumin B

Sarmentosumin B

C43H36O8 (680.2410056)


A natural product found in Piper sarmentosum.

   

6-C-methyl-alpha-D-mannosyl-(1->2)-alpha-D-mannosyl-(1->2)-alpha-D-mannosyl-(1->3)-alpha-D-mannose

6-C-methyl-alpha-D-mannosyl-(1->2)-alpha-D-mannosyl-(1->2)-alpha-D-mannosyl-(1->3)-alpha-D-mannose

C25H44O21 (680.2374973999999)


   

6-[8-(2,4-dihydroxyphenyl)-7-[(2E)-3,7-dimethylocta-2,6-dienyl]-2-(hydroxymethyl)-2-methyl-6-oxopyrano[3,2-g]chromen-5-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

6-[8-(2,4-dihydroxyphenyl)-7-[(2E)-3,7-dimethylocta-2,6-dienyl]-2-(hydroxymethyl)-2-methyl-6-oxopyrano[3,2-g]chromen-5-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid

C36H40O13 (680.246879)


   

Foscan

TEMOPORFIN

C44H32N4O4 (680.2423431999999)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XD - Sensitizers used in photodynamic/radiation therapy D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents D000970 - Antineoplastic Agents C1420 - Photosensitizing Agent D003879 - Dermatologic Agents Same as: D06066

   

6-O-alpha-D-Galactopyranosylciceritol

6-O-alpha-D-Galactopyranosylciceritol

C25H44O21 (680.2374973999999)


   

3-[2-(2-{[3-(2-{2-[(3,4-dihydroxybutanoyl)oxy]propyl}-4,6-dihydroxybenzoyloxy)butanoyl]oxy}propyl)-4,6-dihydroxybenzoyloxy]butanoic acid

3-[2-(2-{[3-(2-{2-[(3,4-dihydroxybutanoyl)oxy]propyl}-4,6-dihydroxybenzoyloxy)butanoyl]oxy}propyl)-4,6-dihydroxybenzoyloxy]butanoic acid

C32H40O16 (680.231624)


   

(1's,2r,2's,3's,4'r,7's,8'z,10'z,12's,13's,14'r,15'r,16'r)-2',12',14',15',16'-pentakis(acetyloxy)-3'-hydroxy-4',13'-dimethyl-5'-oxo-6'-oxaspiro[oxirane-2,17'-tricyclo[11.4.0.0³,⁷]heptadecane]-8',10'-dien-9'-ylmethyl acetate

(1's,2r,2's,3's,4'r,7's,8'z,10'z,12's,13's,14'r,15'r,16'r)-2',12',14',15',16'-pentakis(acetyloxy)-3'-hydroxy-4',13'-dimethyl-5'-oxo-6'-oxaspiro[oxirane-2,17'-tricyclo[11.4.0.0³,⁷]heptadecane]-8',10'-dien-9'-ylmethyl acetate

C32H40O16 (680.231624)


   

1-(2-{2-[(3-amino-8,8-dichloro-1,2-dihydroxyoctylidene)amino]-3-(4-hydroxyphenyl)-n-methylpropanamido}-3-(4-hydroxyphenyl)propanoyl)pyrrolidine-2-carboxylic acid

1-(2-{2-[(3-amino-8,8-dichloro-1,2-dihydroxyoctylidene)amino]-3-(4-hydroxyphenyl)-n-methylpropanamido}-3-(4-hydroxyphenyl)propanoyl)pyrrolidine-2-carboxylic acid

C32H42Cl2N4O8 (680.2379552000001)